Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × isatuximab × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

pembrolizumab 13 Carboplatin 12 Gemcitabine 9 Cisplatin 9 Rituximab 8 Paclitaxel 8 Pemetrexed 7 Ipilimumab 6 Cyclophosphamide 6 osimertinib 5 durvalumab 5 Nivolumab 5 Docetaxel 5 amivantamab 4 Vincristine 4 Prednisone 4 Lenalidomide 4 Dexamethasone 4 trastuzumab deruxtecan 3 olaparib 3 niraparib 3 lazertinib 3 entrectinib 3 daratumumab 3 acalabrutinib 3 Vinorelbine 3 Sorafenib 3 Saline Solution 3 Oxaliplatin 3 Leucovorin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03275285 2026-02-09

IKEMA

Sanofi

Phase 3 Completed

302 enrolled 38 charts 1 FDA

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡